Publication | Closed Access

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours

Stepwise Dose-escalated RegimenPhase I/ii StudyMedicineImmunologyPathologyImmune Checkpoint InhibitorGranulocyte-macrophage Colony-stimulating FactorCancer TreatmentOncologyMalignant DiseaseCancer Research